By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Join Professor John Camm for his discussion on Atrial Fibrillation.
BBC Breakfast News
Patients and network staff talk about their experiences of being involved in clinical research.
Atrial Fibrillation Antiarrhythmic Drugs.
Professor John Camm discusses the two newest antiarrhythmic drugs dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away.
Watch us work.
Now's your chance to watch us work - check out the video below for a snapshot of our bustling team in action.
Transforming clinical trials to accelerate drug development – Keith Berelowitz
August 23, 2022
Dr Keith Berelowitz, Richmond Pharmacology’s Director of Operations, wrote recently for Pharmaceutical Market Europe where he outlined how innovations in the design and delivery of clinical trials are speeding up the discovery of new therapies for the benefit of patients, sponsors and health systems.
Discover the intricacies of assessing abnormal liver functions in clinical trial volunteers and gain insights from the latest drug development trials using RNAi therapeutics.
.svg){kind=small}
-min.jpg)
.jpg)
